Rankings
▼
Calendar
INVA Q1 2022 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena
INVA
Innoviva, Inc.
$1B
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$90M
+5.3% YoY
Gross Profit
$90M
100.0% margin
Operating Income
$78M
86.3% margin
Net Income
$16M
17.5% margin
EPS (Diluted)
$0.20
QoQ Revenue Growth
-16.4%
Cash Flow
Operating Cash Flow
$98M
Free Cash Flow
$98M
Stock-Based Comp.
$954,000
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$555M
Stockholders' Equity
$387M
Cash & Equivalents
$217M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$90M
$86M
+5.3%
Gross Profit
$90M
$85M
+5.4%
Operating Income
$78M
$79M
-2.2%
Net Income
$16M
$94M
-83.2%
Revenue Segments
Royalty
$29M
100%
← FY 2022
All Quarters
Q2 2022 →